Pliant Therapeutics Stock Investor Sentiment

PLRX Stock  USD 1.58  0.04  2.47%   
Slightly above 62% of Pliant Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Pliant Therapeutics stock suggests that many investors are alarmed at this time. Pliant Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Pliant Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
a day ago at gurufocus.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant ...
Gurufocus Stories at Macroaxis
3 days ago at globenewswire.com         
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint...
Macroaxis News: globenewswire.com
3 days ago at gurufocus.com         
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune ...
Gurufocus Stories at Macroaxis
few days ago at globenewswire.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
Macroaxis News: globenewswire.com
few days ago at gurufocus.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant ...
Gurufocus Stories at Macroaxis
six days ago at gurufocus.com         
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
Gurufocus Stories at Macroaxis
six days ago at bizjournals.com         
Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist investor
bizjournals News
over a week ago at www.macroaxis.com         
Acquisition by Coulie Bernard of 325000 shares of Pliant Therapeutics at 11.14 subject to Rule 16b-3
Macroaxis News
over a week ago at globenewswire.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant ...
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
FMR LLC Significantly Reduces Stake in Pliant Therapeutics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
Macroaxis News: globenewswire.com
over two weeks ago at thelincolnianonline.com         
Wells Fargo Company Issues Pessimistic Forecast for Pliant Therapeutics Stock Price
news
over two weeks ago at gurufocus.com         
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant ...
Gurufocus Stories at Macroaxis
over two weeks ago at benzinga.com         
Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future
benzinga news
Far too much social signal, news, headlines, and media speculation about Pliant Therapeutics that are available to investors today. That information is available publicly through Pliant media outlets and privately through word of mouth or via Pliant internal channels. However, regardless of the origin, that massive amount of Pliant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pliant Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pliant Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pliant Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pliant Therapeutics alpha.

Pliant Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.